{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T03:57:36Z","timestamp":1774583856928,"version":"3.50.1"},"reference-count":35,"publisher":"European Respiratory Society (ERS)","license":[{"start":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:00:00Z","timestamp":1732665600000},"content-version":"am","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2024,11,10]]},"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Outpatient management of pulmonary embolism (PE) remains controversial in patients with cancer due to their higher risks of mortality, recurrent venous thromboembolism (VTE) and bleeding complications. This systematic review and meta-analysis aimed to evaluate the safety and feasibility of outpatient management of cancer-associated PE.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We searched MEDLINE, Embase, Cochrane Central, and Scopus databases from inception to May 30, 2024, for studies on outpatient management of cancer-associated PE. Eligible studies included randomized controlled trials, cohort studies, and case-control studies with \u226510 patients. The primary outcome was 30-day-all-cause mortality; secondary outcomes included VTE-related mortality, major bleeding and recurrent VTE at 30\u2005days. Meta-analysis was performed using random effects models, and heterogeneity was assessed with the I<jats:sup>2<\/jats:sup>statistic.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Nineteen studies (13 full-article, 6 abstract-only) with a total of 1589 patients managed as outpatients were identified. Criteria for outpatient management of cancer-associated PE were reported in 14 studies. The pooled 30-day all-cause mortality rate was 1.74% (95% CI: 0.99\u20133.03; I<jats:sup>2<\/jats:sup>=0%, 691 patients, 6 full-article). The 30-day major bleeding pooled rate was 2.71% (95% CI: 1.51\u20134.83; I<jats:sup>2<\/jats:sup>=0%; 406 patients, 6 full-article), and the 30-day recurrent VTE pooled rate was 1.26% (95% CI: 0.53\u20133.00; I<jats:sup>2<\/jats:sup>=0%; 396 patients, 5 full-article).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Selected patients with cancer-associated PE managed as outpatients appear to have low short-term rates of mortality, major bleeding and recurrent VTE suggesting this may be a safe strategy. Further research with larger, prospective studies is needed to confirm these findings and refine risk stratification protocols.<\/jats:p><\/jats:sec>","DOI":"10.1183\/13993003.01596-2024","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T15:41:16Z","timestamp":1732722076000},"page":"2401596","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Outpatient Management of Cancer-Associated Pulmonary Embolism: A Systematic Review and Meta-Analysis"],"prefix":"10.1183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0227-1245","authenticated-orcid":false,"given":"Aur\u00e9lien","family":"Delluc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michelle","family":"Pradier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deborah M.","family":"Siegal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9253-248X","authenticated-orcid":false,"given":"Gr\u00e9goire","family":"Le Gal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Carrier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzu-Fei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2024,11,27]]},"reference":[{"key":"2025040302301014000_65.4.2401596.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60824-6"},{"key":"2025040302301014000_65.4.2401596.2","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1093\/eurheartj\/ehab373","article-title":"Triaging acute pulmonary embolism for home treatment by Hestia or simplified PESI criteria: the HOME-PE randomized trial","volume":"42","author":"Roy","year":"2021","journal-title":"Eur Heart J"},{"key":"2025040302301014000_65.4.2401596.3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2011.04388.x"},{"key":"2025040302301014000_65.4.2401596.4","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2010.199"},{"key":"2025040302301014000_65.4.2401596.5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-144-6-200603210-00010"},{"key":"2025040302301014000_65.4.2401596.6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12245-017-0144-9","article-title":"Discharge or admit? Emergency department management of incidental pulmonary embolism in patients with cancer: a retrospective study","volume":"10","author":"Banala","year":"2017","journal-title":"Int J Emerg Med"},{"key":"2025040302301014000_65.4.2401596.7","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/eurheartj\/ehz367","article-title":"Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial","volume":"41","author":"Barco","year":"2020","journal-title":"Eur Heart J"},{"key":"2025040302301014000_65.4.2401596.8","doi-asserted-by":"crossref","first-page":"vi513","DOI":"10.1093\/annonc\/mdw390.49","article-title":"Outpatient management of cancer-associated pulmonary embolism (PE): analysis of lung carcinoma (LC) cohort from the Epiphany study","volume":"27","author":"Beato","year":"2016","journal-title":"Ann Oncol"},{"key":"2025040302301014000_65.4.2401596.9","first-page":"435","article-title":"Outcome and characteristics of cancer patients with incidental PE managed under a specialised care pathway protocol","volume":"9","author":"Bozas","year":"2011","journal-title":"J Thromb Haemost"},{"key":"2025040302301014000_65.4.2401596.10","first-page":"S70","article-title":"Outpatient treatment for unsuspected pulmonary embolism in cancer patients","volume":"22","author":"Burnod","year":"2014","journal-title":"Support Care Cancer"},{"key":"2025040302301014000_65.4.2401596.11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.thromres.2024.01.014","article-title":"Outpatient management of cancer-associated pulmonary embolism: a post-hoc analysis from the HOME-PE trial","volume":"235","author":"Chaibi","year":"2024","journal-title":"Thromb Res"},{"key":"2025040302301014000_65.4.2401596.12","doi-asserted-by":"crossref","unstructured":"Chatani R , Yamashita Y , Morimoto T , et al. Home treatment for active cancer patients with low-risk pulmonary embolism \u2013 a predetermined companion report from the ONCO PE trial. Circ J 2024; in press. doi:10.1253\/circj.CJ-24-0004","DOI":"10.1253\/circj.CJ-24-0004"},{"key":"2025040302301014000_65.4.2401596.13","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2014.0038"},{"key":"2025040302301014000_65.4.2401596.14","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.thromres.2023.12.003","article-title":"Discharge from the emergency department and outpatient clinic in cancer patients with acute symptomatic and incidental pulmonary embolism: a multicenter retrospective cohort study","volume":"233","author":"Guman","year":"2024","journal-title":"Thromb Res"},{"key":"2025040302301014000_65.4.2401596.15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.thromres.2019.10.031","article-title":"Home treatment of patients with cancer-associated venous thromboembolism \u2013 an evaluation of daily practice","volume":"184","author":"Hendriks","year":"2019","journal-title":"Thromb Res"},{"key":"2025040302301014000_65.4.2401596.16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.9295"},{"key":"2025040302301014000_65.4.2401596.17","first-page":"S186","article-title":"Outpatient management of cancer-related pulmonary embolism: analysis of 562 consecutive patients from the EPIPHANY study","volume":"133","author":"Vicente","year":"2014","journal-title":"Thromb Res"},{"key":"2025040302301014000_65.4.2401596.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1538-7836.2010.03981.x"},{"key":"2025040302301014000_65.4.2401596.19","doi-asserted-by":"crossref","first-page":"S183","DOI":"10.1016\/S0049-3848(12)70110-X","article-title":"Outcome and characteristics of cancer patients with unsuspected PE managed under a specialised care pathway protocol \u2013 updated results","volume":"129","author":"Maraveyas","year":"2012","journal-title":"Thromb Res"},{"key":"2025040302301014000_65.4.2401596.20","first-page":"3063","article-title":"Safety of outpatient management of cancer-associated pulmonary embolism: a retrospective study","volume":"109","author":"Pradier","year":"2024","journal-title":"Haematologica"},{"key":"2025040302301014000_65.4.2401596.21","doi-asserted-by":"crossref","first-page":"e0266305","DOI":"10.1371\/journal.pone.0266305","article-title":"Prediction of serious complications in patients with pulmonary thromboembolism and solid cancer: validation of the EPIPHANY Index in a prospective cohort of patients from the PERSEO study","volume":"18","author":"S\u00e1nchez-C\u00e1novas","year":"2023","journal-title":"PLoS One"},{"key":"2025040302301014000_65.4.2401596.22","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdi923"},{"key":"2025040302301014000_65.4.2401596.23","doi-asserted-by":"crossref","first-page":"3620","DOI":"10.1007\/s11606-021-07289-0","article-title":"Management and outcomes of adults diagnosed with acute pulmonary embolism in primary care: community-based retrospective cohort study","volume":"37","author":"Vinson","year":"2022","journal-title":"J Gen Intern Med"},{"key":"2025040302301014000_65.4.2401596.24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00408-015-9727-5","article-title":"Value of cardiac troponin and sPESI in treatment of pulmonary thromboembolism at outpatient setting","volume":"193","author":"Ozsu","year":"2015","journal-title":"Lung"},{"key":"2025040302301014000_65.4.2401596.25","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1007\/s12094-019-02153-4","article-title":"Outpatient management of incidental pulmonary embolism in cancer patient","volume":"22","author":"Mu\u00f1oz Martin","year":"2020","journal-title":"Clin Transl Oncol"},{"key":"2025040302301014000_65.4.2401596.26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200506-862OC"},{"key":"2025040302301014000_65.4.2401596.27","doi-asserted-by":"crossref","first-page":"e347","DOI":"10.1055\/a-1942-2526","article-title":"The accuracy of Hestia and simplified PESI to predict the prognosis in pulmonary embolism: systematic review with meta-analysis","volume":"6","author":"Palas","year":"2022","journal-title":"TH Open"},{"key":"2025040302301014000_65.4.2401596.28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1007\/s11239-024-02960-9","article-title":"Prediction of mortality in acute pulmonary embolism in cancer-associated thrombosis (MAUPE-C): derivation and validation of a multivariable model","volume":"57","author":"Aramberri","year":"2024","journal-title":"J Thromb Thrombolysis"},{"key":"2025040302301014000_65.4.2401596.29","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1055\/s-0040-1708481","article-title":"A meta-analysis of case fatality rates of recurrent venous thromboembolism and major bleeding in patients with cancer","volume":"120","author":"Abdulla","year":"2020","journal-title":"Thromb Haemost"},{"key":"2025040302301014000_65.4.2401596.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2017.09.015"},{"key":"2025040302301014000_65.4.2401596.31","doi-asserted-by":"crossref","first-page":"102510","DOI":"10.1016\/j.rpth.2024.102510","article-title":"Quality of life in oncological patients with venous thromboembolic disease","volume":"8","author":"Arteaga","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"2025040302301014000_65.4.2401596.32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1711948"},{"key":"2025040302301014000_65.4.2401596.33","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915103"},{"key":"2025040302301014000_65.4.2401596.34","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2018.78.8034"},{"key":"2025040302301014000_65.4.2401596.35","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1111\/jth.15435","article-title":"Outcomes among patients with cancer and incidental or symptomatic venous thromboembolism: a systematic review and meta-analysis","volume":"19","author":"Caiano","year":"2021","journal-title":"J Thromb Haemost"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01596-2024","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T15:35:17Z","timestamp":1747064117000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01596-2024"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":35,"alternative-id":["10.1183\/13993003.01596-2024"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01596-2024","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}